Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [2]
- ELISA [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN566975 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-RPTOR Independent Companion of MTOR, Complex 2 (RICTOR) (AA 1-98), (partial) antibody
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-98, partial
- Isotype
- IgG
- Antibody clone number
- 1F3
- Vial size
- 100 μg
- Storage
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
- Handling
- Aliquot to avoid repeated freezing and thawing.
Submitted references In situ characterization of the mTORC1 during adipogenesis of human adult stem cells on chip.
GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells.
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.
Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes.
Wu X, Schneider N, Platen A, Mitra I, Blazek M, Zengerle R, Schüle R, Meier M
Proceedings of the National Academy of Sciences of the United States of America 2016 Jul 19;113(29):E4143-50
Proceedings of the National Academy of Sciences of the United States of America 2016 Jul 19;113(29):E4143-50
GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells.
Pópulo H, Tavares S, Faustino A, Nunes JB, Lopes JM, Soares P
PeerJ 2013;1:e104
PeerJ 2013;1:e104
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.
Faustino A, Couto JP, Pópulo H, Rocha AS, Pardal F, Cameselle-Teijeiro JM, Lopes JM, Sobrinho-Simões M, Soares P
The Journal of clinical endocrinology and metabolism 2012 Jul;97(7):E1139-49
The Journal of clinical endocrinology and metabolism 2012 Jul;97(7):E1139-49
Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes.
Naïmi M, Gautier N, Chaussade C, Valverde AM, Accili D, Van Obberghen E
Endocrinology 2007 May;148(5):2424-34
Endocrinology 2007 May;148(5):2424-34
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP